MDL studies
ActiveSummary
MDL studies has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €417,519 and a net result of €250,179. Its solvency ranks better than 63% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
Belgian IBD Research and Development
via BAERT Filip · Oud voorzitter en bestuurder
→
former→